Beyond the Hype: Red Biotechnology’s Meteoric Rise Fueled by M&A, Gene Therapy Triumphs, and Strategic Investment
As market valuation barrels towards $1.4 Trillion, industry consolidation and precision medicine breakthroughs redefine the healthcare…
Biopharma M&A